Citius Pharmaceuticals logo

Citius Pharmaceuticals Share Price Today

(NASDAQ: CTXR)

Citius Pharmaceuticals share price is $2.69 & ₹233.46 as on 15 Feb 2025, 2.30 'hrs' IST

$2.69

-0.01

(-0.37%)

Market is closed - opens 8 PM, 18 Feb 2025

View live Citius Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Citius Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Citius Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Citius Pharmaceuticals share price movements

  • Today's Low: $2.65
    Today's High: $2.81

    Day's Volatility :5.61%

  • 52 Weeks Low: $2.44
    52 Weeks High: $26.75

    52 Weeks Volatility :90.88%

Citius Pharmaceuticals (CTXR) Returns

PeriodCitius Pharmaceuticals IncIndex (Russel 2000)
3 Months
-51.83%
0.0%
6 Months
-83.13%
0.0%
1 Year
-86.42%
0.0%
3 Years
-93.49%
-12.5%

Citius Pharmaceuticals (CTXR) Key Statistics

in dollars & INR

Previous Close
$2.7
Open
$2.71
Today's High
$2.8075
Today's Low
$2.65
Market Capitalization
$87.1M
Today's Volume
$104.6K
52 Week High
$26.75
52 Week Low
$2.44
Revenue TTM
$0.0
EBITDA
$-41.1M
Earnings Per Share (EPS)
$-0.24
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-41.49%

How to invest in Citius Pharmaceuticals Stock (CTXR) from India?

It is very easy for Indian residents to invest directly in Citius Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Citius Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Citius Pharmaceuticals or CTXR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Citius Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Citius Pharmaceuticals shares which would translate to 0.323 fractional shares of Citius Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Citius Pharmaceuticals, in just a few clicks!

Returns in Citius Pharmaceuticals (CTXR) for Indian investors in Rupees

The Citius Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Citius Pharmaceuticals investment value today

Current value as on today

₹18,063

Returns

₹81,937

(-81.94%)

Returns from Citius Pharmaceuticals Stock

₹86,469 (-86.47%)

Dollar Returns

₹4,532 (+4.53%)

Indian investors sentiment towards Citius Pharmaceuticals (CTXR)

-20%

Period: Jan 15, 2025 to Feb 14, 2025. Change in 30 Days versus previous period

Search interest for Citius Pharmaceuticals Stock from India on INDmoney has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Citius Pharmaceuticals

  • Armistice Capital, LLC

    3.39%

  • Vanguard Group Inc

    3.00%

  • Geode Capital Management, LLC

    0.87%

  • BlackRock Inc

    0.84%

  • Millennium Management LLC

    0.54%

  • Advisor Group Holdings, Inc.

    0.43%

Analyst Recommendation on Citius Pharmaceuticals

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Citius Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Citius Pharmaceuticals Stock (CTXR)

What analysts predicted

Upside of 73.61%

Target:

$4.67

Current:

$2.69

Insights on Citius Pharmaceuticals Stock (Ticker Symbol: CTXR)

  • Price Movement

    In the last 1 month, CTXR stock has moved down by -24.2%
  • CTXR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.4% return, outperforming this stock by 147.4%
  • CTXR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 78.2% return, outperforming this stock by 171.2%

Citius Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Citius Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Citius Pharmaceuticals (CTXR) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Citius Pharmaceuticals Inc logo
-17.18%
-83.13%
-86.42%
-93.49%
-88.19%
Biontech Se logo
8.01%
36.53%
33.94%
-25.81%
289.28%
Regeneron Pharmaceuticals, Inc. logo
-4.15%
-43.66%
-28.88%
6.87%
69.56%
Vertex Pharmaceuticals Incorporated logo
9.03%
-5.22%
9.56%
96.2%
88.09%
Alnylam Pharmaceuticals, Inc. logo
5.53%
-3.49%
80.2%
72.81%
105.85%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Citius Pharmaceuticals Inc logo
NA
NA
0.0
-0.2
-0.41
-0.25
NA
0.47
Biontech Se logo
160.8
NA
0.04
-3.29
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
17.32
17.32
0.98
43.2
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.19
18.18
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Citius Pharmaceuticals Inc logo
Buy
$87.1M
-88.19%
NA
0.0%
Biontech Se logo
Buy
$27.5B
289.28%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$72.6B
69.56%
17.32
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$116.9B
88.09%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$34.3B
105.85%
NA
-15.86%

About Citius Pharmaceuticals

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for an initial indication in the treatment of cutaneous T-cell lymphoma. Its late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido completed. The company was founded in 2007 and is headquartered in Cranford, New Jersey.
Organization
Citius Pharmaceuticals
Employees
22
CEO
Mr. Leonard L. Mazur
Industry
Health Technology

Management People of Citius Pharmaceuticals

NameTitle
Mr. Leonard L. Mazur
Co-Founder, CEO, Chairman & Secretary
Mr. Myron Z. Holubiak
Co-Founder & Executive Vice Chairman
Dr. Myron S. Czuczman M.D.
Executive VP & Chief Medical Officer
Mr. Jaime Bartushak
Chief Business Officer, CFO & Chief Accounting Officer
Mr. Gary F. Talarico
Executive Vice President of Operations
Ms. Ilanit Allen
Vice President of Investor Relations & Corporate Communications
Dr. Alan Lader Ph.D.
Senior VP and Head of Clinical Operations & Quality Assurance
Mr. Dhananjay G. Wadekar
Senior Vice President of Business Strategy
Mr. Kelly Creighton Ph.D.
Executive Vice President of Chemistry, Manufacturing & Controls
Mr. Nikolas Burlew
Executive Vice President of Quality Assurance

Important FAQs about investing in CTXR Stock from India :

What is Citius Pharmaceuticals share price today?

Citius Pharmaceuticals share price today stands at $2.69, Open: $2.71 ; Previous Close: $2.70 ; High: $2.81 ; Low: $2.65 ; 52 Week High: $26.75 ; 52 Week Low: $2.44.

The stock opens at $2.71, after a previous close of $2.70. The stock reached a daily high of $2.81 and a low of $2.65, with a 52-week high of $26.75 and a 52-week low of $2.44.

Can Indians buy Citius Pharmaceuticals shares?

Yes, Indians can invest in the Citius Pharmaceuticals (CTXR) from India.

With INDmoney, you can buy Citius Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Citius Pharmaceuticals at zero transaction cost.

How can I buy Citius Pharmaceuticals shares from India?

It is very easy to buy Citius Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Citius Pharmaceuticals (CTXR) be purchased?

Yes, you can buy fractional shares of Citius Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Citius Pharmaceuticals stocks?

To start investing in Citius Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Citius Pharmaceuticals Stock (CTXR)?

Today’s highest price of Citius Pharmaceuticals (CTXR) is $2.81.

Today’s lowest price of Citius Pharmaceuticals (CTXR) is $2.65.

What is today's market capitalisation of Citius Pharmaceuticals?

Today's market capitalisation of Citius Pharmaceuticals CTXR is 87.1M

What is the 52 Week High and Low Range of Citius Pharmaceuticals Stock (CTXR)?

  • 52 Week High

    $26.75

  • 52 Week Low

    $2.44

What are the historical returns of Citius Pharmaceuticals (CTXR)?

  • 1 Month Returns

    -17.18%

  • 3 Months Returns

    -83.13%

  • 1 Year Returns

    -86.42%

  • 5 Years Returns

    -88.19%

Who is the Chief Executive Officer (CEO) of Citius Pharmaceuticals ?

Mr. Leonard L. Mazur is the current Chief Executive Officer (CEO) of Citius Pharmaceuticals.